News - MedTech & Diagnostics
World Heart Day sparks call for a ‘real shift’ in priorities and mindset, say Advara Heartcare and Heart Support Australia leaders

Coinciding with World Heart Day 2025, the theme Don’t Miss a Beat strikes a chord far beyond its clever wordplay. It reflects the urgency and complexity of the leading cause of death impacting the nation: cardiovascular disease.
Dr David O’Donnell, Electrophysiologist and CEO of Advara Heartcare, and Dr Christian Verdicchio, CEO of Heart Support Australia and Head of Corporate Affairs & Strategy at Advara Heartcare, bring together perspectives that blend the clinical, strategic, and patient advocacy lenses. Their discussion moves seamlessly from the ESC and CSANZ congresses to the realities of everyday care in Australia, where patients often face significant barriers to care.
Delays in Australia’s reimbursement pathways, including the Prescribed List (PL) and the Pharmaceutical Benefits Scheme (PBS), continue to impact equitable access to innovative health technologies. At the same time, both public and private hospitals are facing mounting pressures around viability and care delivery. Against this backdrop, the two leaders argue that the solutions can’t simply come from more funding alone.
Advara Heartcare’s unique national footprint is presented as one example of how a different model of care can widen patient access, while also creating expanded opportunities to bring clinical trials closer to communities across the country. Layered throughout the podcast is a call for policy and system reform, and a clear reminder of why not missing a beat is about much more than just individual heart health.
In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.
The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.
News - MedTech & Diagnostics
Hearts4heart takes aim at health insurers leaving patients to pay the price
Persistent advocacy by patient groups has prompted the Medical Services Advisory Committee (MSAC) to review the funding gaps for pulsed […]
MoreNews - MedTech & Diagnostics
Queensland first: Private hospitals deploy Abbott’s PFA in atrial fibrillation
More Australians living with atrial fibrillation (AF) are gaining access to one of the latest advances in heart-rhythm treatment, with […]
MoreNews - Pharmaceuticals
Five years of HTA reform talk, now comes the $47 billion question
Medicines Australia has put a $47 billion price tag on what it says Australia must invest to improve equitable access […]
MoreNews - Pharmaceuticals
New MFN deals raise the stakes for Australia’s delayed HTA reform
Four months after the US Trump administration concluded what was expected to be the final tranche of drug-pricing agreements with […]
More